Cargando…
Identification of Novel CB2 Ligands through Virtual Screening and In Vitro Evaluation
[Image: see text] Cannabinoid receptor type 2 (CB2) is a very promising therapeutic target for a variety of potential indications. However, despite the existence of multiple high affinity CB2 ligands, none have yet been approved as a drug. Therefore, it would be beneficial to explore new chemotypes...
Autores principales: | Stasiulewicz, Adam, Lesniak, Anna, Bujalska-Zadrożny, Magdalena, Pawiński, Tomasz, Sulkowska, Joanna I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930120/ https://www.ncbi.nlm.nih.gov/pubmed/36693026 http://dx.doi.org/10.1021/acs.jcim.2c01503 |
Ejemplares similares
-
Identification of CB1 Ligands among Drugs, Phytochemicals
and Natural-Like Compounds: Virtual Screening and In Vitro Verification
por: Stasiulewicz, Adam, et al.
Publicado: (2022) -
A Guide to Targeting the Endocannabinoid System in Drug Design
por: Stasiulewicz, Adam, et al.
Publicado: (2020) -
Mechanisms Underlining Inflammatory Pain Sensitivity in Mice Selected for High and Low Stress-Induced Analgesia—The Role of Endocannabinoids and Microglia
por: Poznanski, Piotr, et al.
Publicado: (2022) -
Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug?
por: Kleczkowska, Patrycja, et al.
Publicado: (2015) -
Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists
por: Ostrowska, Kinga, et al.
Publicado: (2021)